Related Experiment Video

Updated: Jun 13, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Aberrant DNA methylation in malignant melanoma

Carolina Schinke1, Yongkai Mo, Yiting Yu

  • 1Albert Einstein College of Medicine, Bronx, New York, USA.

Melanoma Research
|April 27, 2010
PubMed

Insights

Aberrant DNA methylation is crucial in malignant melanoma development and progression. Targeting these epigenetic changes offers a promising avenue for novel melanoma therapies and prognostic markers.

Area of Science:

  • Oncology
  • Epigenetics
  • Dermatology

Background:

  • Malignant melanoma is a deadly cancer with limited treatment options for advanced stages.
  • Understanding the molecular drivers of melanoma is critical for developing effective therapies.
  • Epigenetic alterations, particularly DNA methylation, play a significant role in melanoma pathogenesis, comparable to genetic mutations.

Purpose of the Study:

  • To review recent findings on aberrant DNA methylation in melanoma.
  • To identify key genes and molecular pathways affected by epigenetic alterations in melanoma.
  • To explore the potential of DNA methylation as a therapeutic target and prognostic marker for melanoma.

Main Methods:

  • Literature review of recent studies on DNA methylation in melanoma.
  • Analysis of key genes and pathways implicated in melanoma development.
  • Evaluation of current clinical investigations into DNA methylation-targeted therapies.

Main Results:

  • Aberrant DNA methylation significantly impacts gene expression in melanoma.
  • Specific genes and molecular pathways are epigenetically altered during melanoma progression.
  • DNA methylation patterns are being investigated for therapeutic intervention and as biomarkers.

Conclusions:

  • Aberrant DNA methylation is a critical factor in malignant melanoma.
  • Targeting DNA methylation pathways holds promise for melanoma treatment.
  • DNA methylation serves as a potential molecular and prognostic marker in melanoma.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...